HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Ambrož Selected Research

Intestinal Neoplasms (Intestinal Cancer)

11/2017The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
1/2016Essential Oil from Myrica rubra Leaves Potentiated Antiproliferative and Prooxidative Effect of Doxorubicin and its Accumulation in Intestinal Cancer Cells.
8/2015The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Ambrož Research Topics

Disease

5Neoplasms (Cancer)
02/2018 - 08/2015
3Intestinal Neoplasms (Intestinal Cancer)
11/2017 - 08/2015
2Obesity
10/2021 - 01/2019
1Colorectal Neoplasms (Colorectal Cancer)
04/2019
1Colonic Neoplasms (Colon Cancer)
03/2019
1Non-alcoholic Fatty Liver Disease
01/2019
1Hypercholesterolemia
01/2019
1Breast Neoplasms (Breast Cancer)
11/2017

Drug/Important Bio-Agent (IBA)

4caryophyllene oxideIBA
03/2019 - 08/2015
4SesquiterpenesIBA
03/2019 - 08/2015
4nerolidolIBA
03/2019 - 08/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2017 - 08/2015
3valenceneIBA
03/2019 - 08/2015
3Cytostatic AgentsIBA
03/2019 - 01/2016
3humuleneIBA
03/2019 - 08/2015
3Volatile Oils (Essential Oils)IBA
06/2017 - 08/2015
2MicroRNAs (MicroRNA)IBA
10/2021 - 01/2019
2Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2019 - 03/2019
2Fluorouracil (Carac)FDA LinkGeneric
04/2019 - 03/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2019 - 01/2016
1Glutathione PeroxidaseIBA
10/2021
1CaspasesIBA
04/2019
1Irinotecan (Camptosar)FDA LinkGeneric
04/2019
1OxidesIBA
03/2019
1FructoseIBA
01/2019
1flubendazoleIBA
02/2018
1AntioxidantsIBA
01/2016
1caryophylleneIBA
08/2015

Therapy/Procedure

3Therapeutics
03/2019 - 01/2016